We join the city of San Francisco in celebrating a victory for public health. Last week, voters approved Proposition E, preserving a local ordinance that prohibits the sale of flavored tobacco products, including menthol cigarettes.
Last week the president introduced a proposal to rein in the cost of prescription medications in the U.S. I commend the administration for prioritizing an issue that so acutely impacts those who have been diagnosed with cancer.
ACS CAN staff, volunteers, childhood cancer patients, survivors and their parents joined forces with the Alliance for Childhood Cancer (Alliance) advocates last month for the Alliance’s seventh annual Legislative Action Day on Capitol Hill in Washington D.C.
Clinical trials are an essential part of advancing new cancer treatments and reducing suffering and death from the disease. However, a significant percentage of cancer clinical trials never get off the ground because not enough patients enroll.
Three years ago, ACS CAN launched the One Degree campaign, calling on Congress to increase federal funding for medical research at the National Institutes of Health (NIH) by $6 billion, including $1 billion for cancer-specific research at the National Cancer Institute (NCI). It was a lofty goal – but an important one to reverse too many years of flat or reduced funding.